beta-hydroxyisovaleric acid has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calhoun, D; Dudenbostel, T; Ellis, AC; Gower, B; Patterson, M | 1 |
| Fuller, JC; Nissen, S; Panton, L; Sharp, RL; Trappe, S; Vukovich, M | 1 |
1 trial(s) available for beta-hydroxyisovaleric acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of 6-month supplementation with β-hydroxy-β-methylbutyrate, glutamine and arginine on vascular endothelial function of older adults.
Topics: Aged; Aged, 80 and over; Aging; Arginine; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Fasting; Female; Glutamine; Humans; Male; Tumor Necrosis Factor-alpha; Valerates; Vasodilation | 2016 |
1 other study(ies) available for beta-hydroxyisovaleric acid and Cardiovascular Diseases
| Article | Year |
|---|---|
beta-hydroxy-beta-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Dietary Supplements; Drug Evaluation; Emotions; Exercise; Female; Humans; Liver Function Tests; Male; Middle Aged; Patient Compliance; Random Allocation; Risk Factors; Valerates | 2000 |